Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma

Guolo Fabio; Minetto Paola; Ballerini Filippo; Canale Filippo Antonio; Frello Michela; Coviello Elisa; Manconi Lorenzo; Kunkl Annalisa; Tedone Elisabetta; Mangerini Rosa; Contini Paola; Fenoglio Daniela; Miglino Maurizio; Bo Alessandra; De Luigi Maria Carla; Ruzzenenti Maria Rosaria; Carlier Paolo; Serio Alberto; Luchetti Silvia; Marcenaro Emanuela; Strada Paolo; Ravetti Jean Louis; Gobbi Marco; Lemoli Roberto Massimo

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma

【24h】

Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma

机译：通过复发/难治性Hodgkin淋巴瘤影响未选择性自体淋巴细胞的未选择性自体淋巴细胞的移植后固结免疫疗法的可行性和有效性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共6页
作者
Guolo Fabio; Minetto Paola; Ballerini Filippo; Canale Filippo Antonio; Frello Michela; Coviello Elisa; Manconi Lorenzo; Kunkl Annalisa; Tedone Elisabetta; Mangerini Rosa; Contini Paola; Fenoglio Daniela; Miglino Maurizio; Bo Alessandra; De Luigi Maria Carla; Ruzzenenti Maria Rosaria; Carlier Paolo; Serio Alberto; Luchetti Silvia; Marcenaro Emanuela; Strada Paolo; Ravetti Jean Louis; Gobbi Marco; Lemoli Roberto Massimo;
展开▼
作者单位

IRCCS Osped Policlin San Martino Dept Internal Med DiMI Clin Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Dept Internal Med DiMI Clin Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Dept Internal Med DiMI Clin Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Dept Internal Med DiMI Clin Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Dept Internal Med DiMI Clin Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Dept Internal Med DiMI Clin Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Dept Internal Med DiMI Clin Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Clin Flow Cytometry Unit Genoa Italy;

IRCCS Osped Policlin San Martino Clin Flow Cytometry Unit Genoa Italy;

IRCCS Osped Policlin San Martino Clin Flow Cytometry Unit Genoa Italy;

IRCCS Osped Policlin San Martino Clin Flow Cytometry Unit Genoa Italy;

Univ Genoa Ctr Excellence Biomed Res Genoa Italy;

IRCCS Osped Policlin San Martino Dept Internal Med DiMI Clin Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Stem Cell Proc Unit Genoa Italy;

IRCCS Osped Policlin San Martino Blood Transfus Serv &

Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Blood Transfus Serv &

Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Blood Transfus Serv &

Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Stem Cell Proc Unit Genoa Italy;

IRCCS Osped Policlin San Martino Stem Cell Proc Unit Genoa Italy;

Univ Genoa Genoa Italy;

IRCCS Osped Policlin San Martino Blood Transfus Serv &

Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Pathol Anat &

Histol Genoa Italy;

IRCCS Osped Policlin San Martino Dept Internal Med DiMI Clin Hematol Genoa Italy;

IRCCS Osped Policlin San Martino Dept Internal Med DiMI Clin Hematol Genoa Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma [J] . Guolo Fabio, Minetto Paola, Ballerini Filippo, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：通过复发/难治性Hodgkin淋巴瘤影响未选择性自体淋巴细胞的未选择性自体淋巴细胞的移植后固结免疫疗法的可行性和有效性
2. Updated Efficacy and Safety Data From the AETHERA Trial of Consolidation With Brentuximab Vedotin After Autologous Stem Cell Transplant (ASCT) in Hodgkin Lymphoma Patients at High Risk of Relapse [J] . Robert W. Chen Clinical advances in hematology & oncology: H&O . 2016,第2Suppla1期

机译：在具有高复发风险的霍奇金淋巴瘤患者中，自体干细胞移植（ASCT）后，通过与以布伦妥昔单抗Vedotin合并的AETHERA试验更新的疗效和安全性数据
3. Updated Efficacy and Safety Data from the AETHERA Trial of Consolidation with Brentuximab Vedotin after Autologous Stem Cell Transplant (ASCT) in Hodgkin Lymphoma Patients at High Risk of Relapse [J] . Sweetenham John W., Walewski Jan, Nadamanee Auayporn, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：在具有高复发风险的霍奇金淋巴瘤患者中，自体干细胞移植（ASCT）后，通过AETHERA与布伦妥昔单抗Vedotin合并的最新疗效和安全性数据
4. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
5. A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure [O] . Kirill V. Lepik, Natalia B. Mikhailova, Elena V. Kondakova, 2020

机译：尼古鲁单抗治疗后复发/难治性霍奇金淋巴瘤患者尼古鲁单抗和苯达莫司汀（NB）的安全性和有效性研究
6. Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma [O] . Fabio Guolo, Paola Minetto, Filippo Ballerini, 2018

机译：通过复发/难治性Hodgkin淋巴瘤影响未选择的自体淋巴细胞再生中未选择的自体淋巴细胞的移植后固结免疫疗法的可行性和功效

Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma

著录项

相似文献

相关主题

期刊订阅